Octapharma Acquires Biovitrum's Plasma Products Division
July 01, 2002 07:27 ET
|
Biovitrum AB
STOCKHOLM, Sweden, July 1, 2002 (PRIMEZONE) -- Biovitrum and Octapharma today announced that an agreement has been signed under which Octapharma will acquire Biovitrum's Plasma Products...
Biovitrum AB Initiates Phase I Clinical Trials for Novel Class Type II Diabetes Compound
March 11, 2002 07:12 ET
|
Biovitrum AB
STOCKHOLM, Sweden, March 11, 2002 (PRIMEZONE) -- Biovitrum (LSE:BIO) today announced that it has entered Phase I studies with BVT.3498, a selective 11B HSD-1 inhibitor for the treatment of Type II...
Biovitrum Completes Successful Phase IIa Trial for Anti-Obesity Treatment (with link)
February 27, 2002 03:17 ET
|
Biovitrum AB
STOCKHOLM, Sweden, Feb. 27, 2002 (PRIMEZONE) -- Biovitrum today announced the positive results of a phase IIa trial for its anti-obesity treatment BVT.933.
"We are delighted to have achieved Proof...